# XTL Biopharmaceuticals Ltd: Form 6-K, filed Jan 5, 2017

- Company: [XTL Biopharmaceuticals Ltd](/companies/xtlb.md) (CIK 1023549)
- Form: 6-K
- Filed: 2017-01-05
- Accepted by EDGAR: Jan 5, 2017, 15:28 ET
- Period: 2017-01-05
- Accession: 0001144204-17-000754
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1023549/000114420417000754/v456302_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1023549/000114420417000754/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1023549/000114420417000754/v456302_6k.htm

Filed Jan 5, 2017.
Source: SEC EDGAR, the filing index for accession 0001144204-17-000754. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.
